Status:
COMPLETED
Vitrous Analysis in Proliferative Diabetic Retinopathy
Lead Sponsor:
Anders Kvanta
Conditions:
Proliferative Diabetic Retinopathy
Eligibility:
All Genders
12+ years
Brief Summary
Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy
Detailed Description
To analyse and compare vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy.
Eligibility Criteria
Inclusion
- proliferative diabetic retinopathy with vitreous hemorrhage
Exclusion
- vitreous hemorrhage of other cause than proliferative diabetic retinopathy
- previous vitrectomy
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2014
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01478763
Start Date
January 1 2011
End Date
September 1 2014
Last Update
September 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Erik Eye Hospital
Stockholm, NonUS, Sweden, 11282